The program is supported through Ferring’s Fertility Out Loud platform and is designed to support both male and female partners through their fertility journey.

Infertility isn’t an easy subject to talk about — and Ferring Pharmaceuticals knows it. Challenges related to family planning have been associated with social stigmatization, particularly for female ...

PARSIPPANY, NJ.--(BUSINESS WIRE)--Ferring Pharmaceuticals today announced the publication in the journal Drugs of its pivotal Phase 3 PUNCH™ CD3 clinical trial data, in which a single dose of ...

As the first FDA-approved fecal microbiota product, Rebyota represents a significant milestone, potentially clearing the way for other such treatments.

Ferring activates first sites in a three-arm study of ADSTILADRIN as a monotherapy or in combination with chemotherapy or an immune checkpoint inhibitor in high-risk Bacillus Calmette-Guérin (BCG ...

Ferring Pharmaceuticals A/S has struck a deal with Royalty Pharma for $500 million, capital it plans to plough into achieving a successful launch of its approved bladder cancer gene therapy, ...

Ferring Pharmaceuticals presented the initial results from an ongoing Phase 3 trial (NCT05704244) in Japan assessing the efficacy and safety of ADSTILADRIN® (nadofaragene firadenovec-vncg) in ...

Ferring Pharmaceuticals has suspended all shipments of its key fertility drug, Menopur. Insider obtained a memo Ferring Pharmaceuticals sent to healthcare providers.

Purvi Tailor, Ferring Pharmaceuticals' VP of HR, says focusing holistically on worker well-being is crucial for retaining top talent in healthcare.

Ferring Pharmaceuticals’ biotherapeutic passed an FDA committee vote for C. difficile despite some skepticism from a handful of members.

These data build on previous studies which have established an estimated point of clinical correspondence for 10 µg follitropin delta to 150 IU follitropin alfa in this class of medications. 1,2 ...